Carotid endarterectomy: what is its current status?
The plethora of recent articles regarding carotid endarterectomy has tended to confuse rather than clarify its indications, efficacy, and acceptability. The National Institutes of Health has recently funded two large multicenter controlled clinical trials, one including asymptomatic persons with carotid stenoses, and the other, patients having transient ischemic episodes or minor strokes. Eight academic professors of neurology (four), neurosurgery (two), and vascular surgery (two) with a long and abiding interest in cerebrovascular disease prepared a statement delineating acceptable levels of mortality and morbidity from this procedure. These might serve as guidelines until the large trials have been completed.
Callow
A D
AD
Department of Neurology, Tufts University School of Medicine, Boston, Massachusetts.
Caplan
L R
LR
Correll
J W
JW
Fields
W S
WS
Mohr
J P
JP
Moore
W S
WS
Robertson
J T
JT
Toole
J F
JF
D001161:Arteriosclerosis / Q000601:surgery; D001241:Aspirin / Q000627:therapeutic use; D002339:Carotid Arteries / Q000601:surgery*; D002340:Carotid Artery Diseases / Q000601:surgery; D002561:Cerebrovascular Disorders / Q000188:drug therapy / Q000517:prevention & control / Q000601:surgery; D002986:Clinical Trials as Topic; D004691:Endarterectomy / Q000009:adverse effects; D006801:Humans
D001241:Aspirin